Reply to Fujimoto <i>et al.</i>: Leveraging Microbiome Composition Variability for Precision Medicine in Idiopathic Pulmonary Fibrosis - KIVIRID

Reply to Fujimoto <i>et al.</i>: Leveraging Microbiome Composition Variability for Precision Medicine in Idiopathic Pulmonary Fibrosis

Authors: David N. O’Dwyer, Imre Noth, Justin M. Oldham

Published: 2024-01-25

DOI: 10.1164/rccm.202312-2262le

Source: Full article

Abstract

No abstract found.